SN

Shubham Nigam

Active Director Director DIN 08578500
DIN 08578500 First appointment Oct 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2019
Shareholding value •••• Premium profile

About Shubham Nigam

Data last updated:

Shubham Nigam is a Director at Medificians Private Limited (since 2019). The company operates in Healthcare. Medificians Private Limited reported revenue of ₹28.9 Lakh (FY 2021).

DIN 08578500
Primary Designation Director
Industry Healthcare
First Appointment 03 Oct 2019
Oldest Company Age 7 yrs
Largest company Medificians Private Limited · ₹28.9 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medificians Private Limited U85194MP2019PTC049718
Director03 Oct 20192019₹28.9 Lakh (FY 2021)Active

Board colleagues of Shubham Nigam

Directorship timeline

Open interactive timeline →
Medificians Private Limited
Premium access

Shareholding and investment profile for Shubham Nigam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shubham Nigam

Shubham Nigam currently holds 1 directorship: Medificians Private Limited (Director, since 03 Oct 2019, revenue ₹28.9 Lakh (FY 2021)).

Shubham Nigam was first appointed on 03 Oct 2019 as Director at Medificians Private Limited.

The current boards of Shubham Nigam's companies include Dushyant Lashkan (Medificians Private Limited), Robin Choudhary (Medificians Private Limited), Shivam Chourishya (Medificians Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available